Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease
| Glavni autori: | , , , , , |
|---|---|
| Format: | Conference item |
| Izdano: |
2007
|
| _version_ | 1826267303570833408 |
|---|---|
| author | Keshav, S Ungashe, S Zheng, W Belker, P Wright, K Schall, T |
| author_facet | Keshav, S Ungashe, S Zheng, W Belker, P Wright, K Schall, T |
| author_sort | Keshav, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T20:52:07Z |
| format | Conference item |
| id | oxford-uuid:37f13f4e-8a9b-4ad1-8f4d-cc5bad788a48 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T20:52:07Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:37f13f4e-8a9b-4ad1-8f4d-cc5bad788a482022-03-26T13:46:58ZCcx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's diseaseConference itemhttp://purl.org/coar/resource_type/c_5794uuid:37f13f4e-8a9b-4ad1-8f4d-cc5bad788a48Symplectic Elements at Oxford2007Keshav, SUngashe, SZheng, WBelker, PWright, KSchall, T |
| spellingShingle | Keshav, S Ungashe, S Zheng, W Belker, P Wright, K Schall, T Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title_full | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title_fullStr | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title_full_unstemmed | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title_short | Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease |
| title_sort | ccx282 b an orally active inhibitor of chemokine receptor ccr9 shows anti inflammatory and clinical activity in the treatment of crohn s disease |
| work_keys_str_mv | AT keshavs ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease AT ungashes ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease AT zhengw ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease AT belkerp ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease AT wrightk ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease AT schallt ccx282banorallyactiveinhibitorofchemokinereceptorccr9showsantiinflammatoryandclinicalactivityinthetreatmentofcrohnsdisease |